Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Gastroenterology & Hepatology|August 6, 2016
Fecal Microbiota Transplantation for Inflammatory Bowel DiseaseJoanna Lopez, Ari Grinspan
Current Gastroenterology Reports|July 6, 2015
Positioning Therapy for Ulcerative ColitisAri Grinspan, Asher Kornbluth
Digestive Diseases and Sciences|January 9, 2022
Fecal Microbiota Transplant for Clostridioides Difficile Infection Is Safe and Efficacious in an Immunocompromised CohortKelly Suchman, Yuying Luo, Ari Grinspan
Journal of Clinical Gastroenterology|January 20, 2021
Oral Fecal Microbiota Transplant Capsules Are Safe and Effective for Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-AnalysisCharles Du, Yuying Luo, Samantha Walsh, et al.
Intestinal Failure (New York, N.Y.)|February 6, 2026
Safe and successful fecal microbiota transplantation for recurrent Clostridioides difficile infection in a child with an intestinal transplantJuliana Kennedy, Kishore Iyer, Ari Grinspan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 30, 2019
Patients Eligible for Trials of Microbe-Based Therapeutics Do Not Represent the Population With Recurrent Clostridioides difficile InfectionColleen R Kelly, Monika Fischer, Ari Grinspan, et al.
Journal of Digestive Diseases|October 2, 2022
Fecal microbiota transplantation may reduce the mortality of patients with severe and fulminant Clostridioides difficile infection compared to standard-of-care antibiotics in a community hospitalMaria Mironova, Adam C Ehrlich, Ari Grinspan, et al.
Journal of Pediatric Gastroenterology and Nutrition|October 16, 2018
Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection in Pediatric Inflammatory Bowel DiseaseStanley Cho, Elizabeth Spencer, Robert Hirten, et al.
Crohn'S & Colitis 360|February 13, 2023
A Systematic Review of Fecal Microbiota Transplant for the Management of PouchitisMaia Kayal, Thomas Lambin, Rachel Pinotti, et al.
The American Journal of Gastroenterology|March 19, 2024
Outcomes After Fecal Microbiota Transplantation in Combination With Bezlotoxumab for Inflammatory Bowel Disease and Recurrent Clostridioides difficile InfectionJessica R Allegretti, Jordan Axelrad, Rahul S Dalal, et al.
Pageof 4